Skip to main content

Grafa News and Videos — Page 1224

Latest

Grafa

Gilead extends WHO partnership to eliminate second-deadliest parasitic disease

Gilead Sciences (NASDAQ:GILD) announced a renewed five-year collaboration framework with the World Health Organization (WHO), extending an institutional partnership targeted at eliminating visceral leishmaniasis (VL) as a public health threat by 2030.

Read more: Gilead extends WHO partnership to eliminate second-deadliest parasitic disease

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift